Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment (PCV)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration; Choroidal neovascularisation
- Focus Therapeutic Use
- 07 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2017.
- 30 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2016.
- 30 Aug 2016 Status changed from recruiting to active, no longer recruiting.